v3.26.1
STOCKHOLDERS' DEFICIT (Tables)
6 Months Ended
Jun. 30, 2026
STOCKHOLDERS' DEFICIT  
Summary of the Company's option activity

​

​

​

​

​

​

​

​

​

​

For the Six months ended

​

​

June 30, 2026

​

  ​ ​ ​

​

  ​ ​ ​

Weighted

  ​ ​ ​

 

​

​

​

​

average

​

Aggregate

​

​

Amount of

​

exercise

​

intrinsic

​

​

options *

​

price

​

value

​

​

​

​

$

​

$

Outstanding at December 31, 2025

 

51,656

​

34.19

 

—

Granted

 

1,512,500

​

0.70

 

—

Cancelled

 

(2,978)

​

13.22

 

—

Outstanding at June 30, 2026

 

1,561,178

​

1.78

 

—

Exercisable at June 30, 2026

 

802,387

​

2.61

 

—

*   Represents Employee Stock Options only (not including RSUs).

Schedule of restricted stock activity

​

​

​

​

​

​

​

​

​

  ​ ​ ​

​

  ​ ​ ​

​

  ​ ​ ​

Weighted Average

​

​

​

​

​

​

Remaining

​

​

Number of Shares

​

Weighted Average

​

Contractual

​

​

of Restricted

​

Grant Date Fair

​

Term

​

​

Stock

​

Value

​

(Years)

Nonvested as of December 31, 2025

 

310,854

​

3.01

 

0.45

Granted

 

2,680,000

​

0.70

 

—

Vested

 

1,647,604

​

1.07

 

—

Forfeited

 

—

​

—

 

—

Nonvested as of June 30, 2026

 

1,343,250

 

0.78

 

0.16

Schedule of total stock-based compensation expense

​

​

​

​

​

​

​

​

​

​

Six months ended

​

​

June 30,

​

  ​ ​ ​

2026

  ​ ​ ​

2025

Research and development

​

$

466

​

$

247

General and administrative

​

​

1,911

​

​

470

Total stock-based compensation expense

​

$

2,377

​

$

717